Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Berna Cakmak, Oksuzoglu"'
Autor:
Ece Esin, Omur Berna Cakmak Oksuzoglu, Erkan Erdur, Ozgen Ahmet Yildirim, Guliz Zengin, Aysegul Ilhan, Ulku Arslan, Umut Demirci
Publikováno v:
Journal of Oncological Sciences, Vol 4, Iss 1, Pp 11-14 (2018)
Introduction: With the development and widely use of HER2 targeted therapies, HER2 expressing metastatic breast cancer have no longer dismal prognosis as once expected. The combination of HER2 targeted therapies with chemotherapatic agents prolongs o
Externí odkaz:
https://doaj.org/article/03311287c803444994b128dd10098e1d
Autor:
Serdar, Karakaya, Ibrahim, Karadag, Cigdem, Ozdilekcan, Esra, Durmusoglu, Ozturk, Ates, Omur Berna, Cakmak Oksuzoglu
Publikováno v:
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP. 32(3)
To investigate whether the use of diffusing capacity of the lungs for carbon monoxide (DLCO) and neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) could be used to predict bleomycin-induced pulmonary toxicity in patients with t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::795962723b19ab651ffb6f1cda4f7fd2
https://pubmed.ncbi.nlm.nih.gov/35148592
https://pubmed.ncbi.nlm.nih.gov/35148592
Autor:
Ummugul Uyeturk, Gulali Aktas, Burcin Budakoglu, Ulku Yalcıntas Aslan, Mustafa Sit, Omur Berna Cakmak Oksuzoglu
Publikováno v:
National Journal of Medical Research, Vol 3, Iss 03 (2013)
Background: Gastrointestinal stromal tumors (GIST) are rare mesenchimal tumors may develop in any site in the gastrointestinal system. KIT gene mutations are detected in 95% of cases. In this study, we aimed to assess treatment options and general ch
Externí odkaz:
https://doaj.org/article/677b5915d2ce421fb7902ac6b30dfce3
Autor:
Ahmet, Siyar Ekinci, Umut, Demirci, Berna, Cakmak Oksuzoglu, Ayse, Ozturk, Onur, Esbah, Tahsin, Ozatli, Burcin, Celik, Burcin, Budakoglu, Ibrahim, Turker, Oznur, Bal, Nedim, Turan
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 20(1)
Adding targeted therapies to chemotherapy in metastatic colorectal cancer (CRC) improves response rates and survival. KRAS is a predictive indicator for anti-epidermal growth factor receptor (EGFR) treatments. The most important reasons for KRAS disc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9aa7d10ccbb8a514369e78ef15fa8317
https://pubmed.ncbi.nlm.nih.gov/25778307
https://pubmed.ncbi.nlm.nih.gov/25778307
Autor:
Dogan, Uncu, Nuriye Yildirim, Ozdemir, Sercan, Aksoy, Huseyin, Abali, Berna Cakmak, Oksuzoglu, Burçin, Budakoglu, Ramazan, Yildiz, Nalan, Aslan, Nurullah, Zengin
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP. 11(6)
Chemotherapy and radiotherapy are approved in clinical practice of adjuvant treatment of gastric carcinoma. In present study, we retrospectively evaluated the efficacy and tolerability of an adjuvant treatment protocol including bi-weekly cisplatin,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6cfb3862941c7971c3a6a64834bcb900
https://pubmed.ncbi.nlm.nih.gov/21338186
https://pubmed.ncbi.nlm.nih.gov/21338186